Author Question: What is the action of COX-2 inhibitors? What will be an ideal ... (Read 19 times)

penguins

  • Hero Member
  • *****
  • Posts: 903
What is the action of COX-2 inhibitors?
 
  What will be an ideal response?

Question 2

What is pneumothorax? When does it usually occur?
 
  What will be an ideal response?



b614102004

  • Sr. Member
  • ****
  • Posts: 320
Answer to Question 1

Selectively inhibit the COX-2 enzyme that promotes the synthesis of prostaglandins that function as mediators of inflammation.

Answer to Question 2

When air flows into the pleural space where the lung or chest wall is punctured, the subatmospheric pressure that holds the lung in the expanded position is lost and the lung collapses because the elastic tissue within the lung contracts. This is pneumothorax. This condition may follow any type of lung injury or pulmonary disease that allows air to escape from the lungs into the pleural space. It may also occur as a result of a stab wound or some other penetrating injury to the chest wall that permits atmospheric air to enter the pleural space. Occasionally spontaneous pneumothorax occurs without apparent cause.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Fewer than 10% of babies are born on their exact due dates, 50% are born within 1 week of the due date, and 90% are born within 2 weeks of the date.

Did you know?

Never take aspirin without food because it is likely to irritate your stomach. Never give aspirin to children under age 12. Overdoses of aspirin have the potential to cause deafness.

Did you know?

In the United States, an estimated 50 million unnecessary antibiotics are prescribed for viral respiratory infections.

Did you know?

Drugs are in development that may cure asthma and hay fever once and for all. They target leukotrienes, which are known to cause tightening of the air passages in the lungs and increase mucus productions in nasal passages.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library